INTERVENTIONAL CARDIOLOGY
Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures
Allen Jeremias, MD*, ,
Donald S. Baim, MD, FACC*, ,
Kalon K.L. Ho, MD, MS, FACC*,,
Manish Chauhan, MD, FACC,
Joseph P. Carrozza, Jr, MD, FACC*,
David J. Cohen, MD, MS*,,
Jeffrey J. Popma, MD, FACC,
Richard E. Kuntz, MD, MS*, and
Donald E. Cutlip, MD, FACC*,,*
* Harvard Clinical Research Institute
Division of Cardiology, Beth Israel Deaconess Medical Center
Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA
Manuscript received March 17, 2004;
revised manuscript received May 5, 2004,
accepted June 7, 2004.
* Reprint requests and correspondence: Dr. Donald E. Cutlip, Interventional Cardiology Section, Beth Israel Deaconess Medical Center, One Deaconess Road, Baker 4, Boston, Massachusetts 02215 (Email: dcutlip{at}bidmc.harvard.edu).
OBJECTIVES: This study was designed to evaluate the effect of periprocedural myocardial infarction (MI) on mortality according to success of the stent procedure.
BACKGROUND: The mortality effect of periprocedural MI relative to successful versus unsuccessful procedures has not been examined.
METHODS: All-cause mortality during the first year was evaluated prospectively among 5,850 patients from coronary stent clinical trials. Myocardial infarction was classified according to creatine kinase-MB level as type 1 (>1 but <3 times normal), type 2 ( 3 but  8 times normal), or type 3 (>8 times normal or Q-wave MI). Procedures were classified as successful unless there was a final diameter stenosis >50%; final Thrombolysis In Myocardial Infarction flow grade <3; final National Heart, Lung, and Blood Institute dissection grade D; repeat revascularization within 24 h; or stent thrombosis within 24 h.
RESULTS: Myocardial infarction was more frequent after unsuccessful procedures (69.6% vs. 20.4%, p < 0.001). Mortality during the first year was higher in patients with MI (2.8% vs. 1.7%, p = 0.01), but the effect was significant only for type 3 MI (4.7% vs. 1.7%, p = 0.008). Moreover, the mortality difference for any MI was confined to patients with unsuccessful procedures (13.1% vs. 0%, p = 0.03), with no significant effect among patients with otherwise successful procedures (2.1% vs. 1.7%, p > 0.20). The independent predictors of mortality were unsuccessful procedure (p < 0.001), diabetes mellitus (p = 0.001), history of prior MI (p = 0.003), multivessel disease (p = 0.006), and advancing age (p < 0.001), but not periprocedural MI.
CONCLUSIONS: The association of periprocedural MI with increased mortality during the first year following stent placement was confined to patients with unsuccessful procedures.
|
Abbreviations and Acronyms
| | CK-MB = creatine kinase-MB | | MI = myocardial infarction | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:
|
|
|
|
 
H. L. Dauerman
Percutaneous Coronary Intervention Pharmacology From a Triangle to a Square.
J. Am. Coll. Cardiol.,
February 19, 2008;
51(7):
698 - 700.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Larose
Below Radar: Contributions of Cardiac Magnetic Resonance to the Understanding of Myonecrosis After Percutaneous Coronary Intervention
Circulation,
August 15, 2006;
114(7):
620 - 622.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D P Chew, D L Bhatt, A M Lincoff, K Wolski, and E J Topol
Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk
Heart,
July 1, 2006;
92(7):
945 - 950.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Bhatt and E. J. Topol
Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes
Circulation,
August 9, 2005;
112(6):
906 - 922.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Cutlip and R. E. Kuntz
Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes
Circulation,
August 9, 2005;
112(6):
916 - 923.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P.A. Ioannidis, E. Karvouni, and D. G. Katritsis
Creatine Kinase-MB Elevation Following Stent Implantation
J. Am. Coll. Cardiol.,
June 7, 2005;
45(11):
1908 - 1908.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Jeremias, D. S. Baim, R. E. Kuntz, and D. E. Cutlip
Reply
J. Am. Coll. Cardiol.,
June 7, 2005;
45(11):
1908 - 1909.
[Full Text]
[PDF]
|
|
|
|
